<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33-biomolecules-10-01148">
 <label>33.</label>
 <element-citation publication-type="patent">
  <person-group person-group-type="author">
   <name>
    <surname>Boryczka</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Chrobak</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Bębenek</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Kadela-Tomanek</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dąbrowska</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chilmonczyk</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Wiktorska</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Milczarek</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Chrobak</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Anti-HIV-1 Phosphate Derivatives of 3-carboxyacylbetulin, Their Preparation and Their Use</article-title>
  <source>R.P. Patent</source>
  <patent>Application No. P.430836</patent>
  <day>7</day>
  <month>8</month>
  <year>2019</year>
 </element-citation>
</ref>
